Top of Page
Skip main navigation

Reboot Study: TNF & Glucocorticoid Antagonist for GWI Associated Multi-Symptom Disease Hemostasis Reset

Now Recruiting! This dosage finding study will evaluate the safety, effectiveness and biological response to two medications (TNF and Glucocorticoid receptor antagonists) in changing your bodies “sick response” of GWI into a more permanently healthy condition.

For more information, please contact us at 954-262-2870 or email GWICTIC@nova.edu.

 

Visit ClinicalTrials.gov for study record details. 

 

 

 

Return to GWICTIC Studies

Return to top of page